BIOMEDICAL RESEARCH AND REVIEWS

ISSN 2631-3944

Nursery Education in Schools, Significance for Career

Da-Yong Lu1*, Yu-Zheng Chen2, Da-Feng Lu2

1 School of Life Sciences,  Shanghai University, Shanghai, China
2 The Second Hospital of Neijiang District, Sichuan Province, China

CitationCitation COPIED

Lu DY, Yu-Zheng CY, Feng LD, Nursery Education in Schools, Significance for Career. Biomed Res Rev. 2019 Dec;2(3):113

Abstract

Nursery education in schools plays key roles for medical practice in nurse career. To promote medical and technical work, different nursery training systems and multidisciplinary medicines are introduced and discussed-including which character and quality is most important for students in nursery schools. This article addresses nursery training systems and disciplines that students may learn from and benefit for whole life.

Keywords

Healthcare; Nursing; Medical Service; Modern Technology; Education; Personalized Medicine; Obesity; Psycho-Analysis

Introduction

Medical care and nursing advances greatly improve patient’s recovery and disease controls in the clinic. The medical significance of the quality promotion of nursing activity and satisfactory is notable [1-7]. This editorial addresses this interesting topic from new insights.

Methods

The key for nursery study and practice is the nurse quality buildup; it includes different and important quality of Responsibility, Cooperative ability, Communication skills, Carefulness, Literary skills, Insist braveness (not always a good thing) and others [8-11].

These qualities should be translated into academic performance, levels and grades of nursery students in the nursery schools. These different qualities should be well represented in their college grades and useful for the hospitals that may choose nurses in the future.

Results

Through quality buildup, the nurses can enter into the hospitals and familiar with work in different departments (Table 1) shows category of nurses in general discipline [12-15]. Nurses can integrate these two spectrums of medical knowledge and finally into their nursery careers (Table 1).

Major disciplines
Technical catalog
Requirements
Surgery and anesthesia
Local or whole-body
Individual conditions
Psychiatric
Cognitive, behavior and emotional
Suicidal risk and custody
Emergency
Blood, respiratory and life indicates
Testing and support
Pharmacology
Efficacy and toxicity monitors
Careful observation 
Nursery
Different medical disciplines
Physical and spiritual
Patient condition
Gender and ages
Emphasize for categories

Table 1: Medical service by entering into hospitals

Currently, different medications are gearing up in more global hospitals. It is very difficult to teach all types of medical information for nurses. Medical knowledge is not at the top of nursery training for economic consideration.

Discussion

Major medical knowledge training in nurse career should be a future trend; including medical information of different disease categories and therapeutic disciplines. Through these medical training, nurses may be more happy in their work and update their quality obviously.

Emergency medication [16,17], Viral infection and treatments [18,19] , Mental diseases [20-22], Bone disorders [23-24], Metabolic diseases (type 2 diabetes and obesity) [25-33], Cancer metastasis treatments [34-38], Multi-targeted drugs and herbal medicine [39,40], Personalized (precision) medicine [41-45], Palliative treatments [46-48].

After all, nurses should be familiar with all these knowledge of medical disciplines and execute their service in high quality. Nursery school should carefully teach, organize and monitor student learning. They can even organize students to go abroad and learn medical systems of other countries [11]. After these abroad experiences, nurse students may find jobs of other countries.

Conclusion

Nursery services in the hospitals are affected by nurse education and training. Many work and organization need to promote. Overall, nursery training should be more emphasized at different stages [49]. Many new nursery training systems can be built from systematic investigations and study.

References

  1. Lu DY, Chen YZ, Lu DF, Che JY. Patient’s care and nursery in different diseases. Hospice & Palliative Medicine International Journal. 2019 Feb;3(1):28-30. (Ref)
  2. Lu DY, Chen YZ, Lu DF, Che JY. Patient’s care and nursery in modern medicine. Nurs Pract Health Care. 2019 Feb;1(1):1-2. (Ref)
  3. Lu DY, Chen YZ, Lu DF. Nursery education, capability and service promotion. Open Access J Nursery. 2019;2(2):1-4. (Ref)
  4. Iqbal U, Humayyn A, Li YJ. Healthcare quality improvement and measurement strategies and its challenges ahead. Int J Qual Health Care. 2019 Feb;31(1):1. (Ref)
  5. Iqbal U, Rabrenovic M, Li YJ. Health care quality challenges in low- and middle-income countries. Int J Qual Health Care. 2019 Apr;31(3):165. (Ref)
  6. Lu DY, Che JY, Putta S, Wu HY, Shen Y. How to improve the quality of pharmacotherapy for bone diseases. EC Orthopaedicis. 2019 May;10(6):366-369. (Ref)
  7. Leebov W, Scott G. Service quality improvement. The customer satisfaction strategy for healthcare. J Healthcare Quality. 1996; 18(4):35.
  8. Kwag YK. A study of clinical nurses’ perception on nursing student character development levels and requirement of character education virtue for nursing students. J Comprehensive Nursing Res Care. 2019; 4:147. (Ref)
  9. Alzghool MM, Al-Bakiri AM. The future of mental health nursing practice in Saudi Arabia: A delphi study. J Comp Nurs Res Care. 2019 Jan;4:132. (Ref)
  10. Miyazaki T. The use of virtual reality learning materials in nursing seminar and its possibility. J Comp Nurs Res Care. 2019; 4:138. (Ref)
  11. Naber J, Hale A. A nursing study abroad experience in the blue zone of Sardinia, Italy: A case study of the program and development. J Comprehensive Nursing Res Care.2019;4: 146. (Ref)
  12. Lu DY, Chen YZ, Lu DF. Nursery service, quality promotion. Hospice & Palliative Medicine International Journal. 2019 May;3(3):97-98. (Ref)
  13. Lu DY, Chen YZ, Lu DF, Che JY. Nursery service in modern day. Adv Biomedical Engineering Biotechnology. 2019; 1(3): 1-2.
  14. Ghaffari M. Building a community of learners: Lessons learned. Nursery Practice and Health Care. 2019; 1 (1): 104. 
  15. Lu DY, Chen YZ, Lu DF. Nursery science and conventions. Nurs Health Care Int J. 2019 Sep;3(5):2-3. (Ref)
  16. Lu DY, Shen Y, Xu B. Heart and brain stroke, a paramount task for emergency medication. EC Emergency Medicine and Critical Care. 2019; 3(10):785.
  17. Khan M, Silver B. Editorial: Stroke in elderly: current status and future direction. Front Neurol. 2019 Mar;10:177. (Ref)
  18. Lu DY, Wu HY, Yarla NS, Xu B, Ding J, et al. HAART in HIV/AIDS treatments: Future trends. Infectious Disorders-Drug Targets. 2018;18(1):15-22. (Ref)
  19. Lu DY. HIV/AIDS Treatments, Fight for a Cure. LAMBERT Academic Publishing. Ed Da-Yong Lu, 2017, Germany (ISBN-978- 3-330-07665-5). (Ref)
  20. Serafini G, Salano P, Amore M. Suicidal ideation: a comprehensive overview. Suicidal Ideation: Predictors, Prevalence and Prevention. Ed. Bradley Weaver. Nova Science Publishing. US, 2015; 1:1-42. (Ref)
  21. Lu DY. Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed Da-Yong Lu, Nova Science Publishers, 2017, New York, US (ISBN-978-1-53610-601-5). (Ref)
  22. Lu DY, Zhu PP, Wu HY, Yarla NS, Xu B, et al. Human suicide risk and treatment study. Cent Nerv Syst Agents Med Chem. 2018 Aug;18(3):206-212. (Ref)
  23. Melton LJ. Hip fracture; a worldwide problem today and tomorrow. Bone. 1993;14:S1-S8. (Ref)
  24. Lu DY, Che JY, Shen ZM, Tong LJ, Lin LP, Shen Y. Osteoporosis treatments for old people. EC Orthopeadicis. 2019; 10(5): 278- 280. (Ref)
  25. Putta S, Peluso I, Yarla NS, Kilari EK, Bishayee A, et al. Diabetes mellitus and male aging, pharmacotherapeutics and clinical implications. Curr Pharm Des. 2017;23(30):4475-4483. (Ref)
  26. Lu DY, Che JY, Yarla NS, Zhu H, Lu TR, et al. Type 2 diabetes study, introduction and perspective. The Open Diabetes J. 2018;8:13-21. (Ref)
  27. Lu DY, Che JY, Yarla NS, Wu HY, Lu TR, et al. Type 2 diabetes treatment and drug development study. The Open Diabetes J. 2018;8:22-33. (Ref)
  28. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes; a 21st century challenge. Lancet Diabetes Endocrinol. 2014 Jan;2(1):56- 64. (Ref)
  29. Grimaccia F, Kanavos P. Cost, outcome, treatment pathways and challenges for diabetes care in Italy. Globalization Health. 2014 Jul;10(1):58. (Ref)
  30. Lu DY, Che JY, Lu Y, Yarla NS, Xu B, et al. An overview of obesity. Metabolomics. 2018; 8(2):200. (Ref)
  31. Lu DY, Che JY, Wu HY, Yarla NS, Xu B, et al. Obesity, risks and managements. Metabolomics. 2018;8(1):e156. (Ref)
  32. Lu DY, Che JY, Lu TR, Lu Y, Huang YK, et al. Pathology and treatments of obesity. Trends in Medicine. 2018;8(5):157. (Ref)
  33. Lu DY, Che JY, Yarla NS, Putta S, Lin LP, et al. Human obesity, pathological and therapeutic advances. EC Pharmacol Toxicol. 2019 Mar;7 (4):231-238. (Ref)
  34. Lu DY, Lu TR, Wu HY, Cao S. Cancer Metastasis treatments. Current Drug Therapy. 2013; 8(1):24-29. (Ref)
  35. Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016 Jun;166(1):21-45. (Ref)
  36. Lu DY, Xu B, Ding J. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo. BMC Pharmacology. 2004 Dec;4:32. (Ref)
  37. Lu DY, Chen XL, Ding J. Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. Med Hypotheses. 2007;68(1):188-193. (Ref)
  38. Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017 Feb;168(4):670-691. (Ref)
  39. Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, et al. Anthocyanins: Possible role as multitarget therapeutic agents for prevention and therapy of chronic diseases. Curr Pharm Des.  2017;23(30):4475-4483. (Ref)
  40. Lu DY, Lu TR. Herbal medicine in new era. Hospice Palliative Medicine International J. 2019 Jun;3(4):125-130. (Ref)
  41. Lu DY. Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics. Woodhead Publishing, Elsevier. 2014 Dec. (Ref)
  42. Lu DY, Lu TR, Ding J, Xu B, Che JY, et al. Anticancer drug sensitivity testing, a historical review and future perspectives. Current Drug Therapy. 2015 Nov;10(1):44-55. (Ref)
  43. Lu DY, Lu TR, Xu B, Ding J. Pharmacogenetics of cancer therapy: breakthroughs from beyond? Future Sci OA. 2015 Nov;1(4). (Ref)
  44. Lu DY, Lu TR, Che JY, Yarla NS. Individualized cancer therapy, what is the next generation? EC Cancer. 2018 Jun;2(6):286-297. (Ref)
  45. Lu DY, Lu TR, Che JY, Shen Y, Yarla NS. Individualized cancer therapy, future approaches. Curr Pharmacogenomics Person Med. 2018;16(2):156-163. (Ref)
  46. Kapil M, Verma A, Sareen R, Gupta GN. Palliative care-a small step, big result, an effort to achieve. Hospice Palliative Medicine International J. 2019;3(5):149-150. (Ref)
  47. Prityko DA, Burkov IV, Safonov VV, Klimov DE, Gusev L. Palliative care for children, problems and ways to solve them. EC Clin Exp Anat. 2019 Oct;2(9):23-29. (Ref)
  48. Lu DY, Wu HY, Shen Y, Xu B, Lu TR. Medical treatments for incurable diseases, palliative therapy. Hospice Palliative Medicine International J. 2019;3 (5):175-176. (Ref)
  49. Lu DY, Chen YZ, Lu DF. Nursery training, from technical details in schools into medical knowledge education in nursery career. Hospice Palliative Medicine International J. 2019;3(5):163-165. (Ref)